The application of prague C and M criteria in the diagnosis of barrett's esophagus in an ethnic chinese population

American Journal of Gastroenterology

Volumn 104, Issue 1, 2009, Pages 13-20

  Chang, Chi Yang ^a,b,c   Lee, Yi Chia ^b,c   Lee, Ching Tai ^a   Tu, Chia Hung ^a   Hwang, Jau Chung ^a   Chiang, Hung ^d   Tai, Chi Ming ^a   Chiang, Tsung Hsien ^a   Wu, Ming Shiang ^b   Lin, Jaw Town ^a,b  

^a I SHOU UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d Taipei Institute of Pathology   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BARRETT ESOPHAGUS; CHINESE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENDOSCOPIC BIOPSY; ENDOSCOPICALLY SUSPECTED ESOPHAGEAL METAPLASIA; ENDOSCOPY; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS DISEASE; ETHNIC GROUP; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; PATIENT REFERRAL; PRAGUE C AND M CRITERIA; PREVALENCE; PRIORITY JOURNAL; SCREENING; ASIAN; CLASSIFICATION; DIGESTIVE TRACT ENDOSCOPY; ESOPHAGITIS; MIDDLE AGED; PATHOLOGY; TAIWAN;

ASIAN CONTINENTAL ANCESTRY GROUP; BARRETT ESOPHAGUS; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; TAIWAN;

EID: 60749108443     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2008.43     Document Type: Article

References (54)

1. Spechler SJ, Goyal RK. Barretfs esophagus. N Engl J Med 1986;315:362-71.
2. Vakil N, van Zanten SV, Kahrilas P et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-20; quiz 43.
3. Ronkainen J, Aro R Storskrubb T et al. Prevalence of Barretfs esophagus in the general population: an endoscopic study. Gastroenterology 2005;129:1825-31.
4. Jankowski JA, Provenzale D, Moayyedi P. Esophageal adenocarcinoma arising from Barretfs metaplasia has regional variations in the west. Gastroenterology 2002;122:588-90.
5. O'Connor JB, Falk GW, Richter JE. The incidence of adenocarcinoma and dysplasia in Barretfs esophagus: report on the Cleveland Clinic Barretfs Esophagus Registry. Am J Gastroenterol 1999;94:2037-42.
6. Winters C Jr., Spurling TJ, Chobanian SJ et al. Barretfs esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987;92:118-24.
7. Cameron AJ, Lomboy CT. Barretfs esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology 1992;103:1241-5.
8. Hirota WK, Loughney TM, Lazas DJ et al. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999;116:277-85.
9. Blustein PK, Beck PL, Meddings JB et al. The utility of endoscopy in the management of patients with gastroesophageal reflux symptoms. Am J Gastroenterol 1998;93:2508-12.
10. Westhoff B, Brotze S, Weston A et al. The frequency of Barrett's esophagus in high-risk patients with chronic GERD. Gastrointest Endosc 2005;61: 226-31.
11. Csendes A, Smok G, Burdiles P et al. Prevalence of intestinal metaplasia according to the length of the specialized columnar epithelium lining the distal esophagus in patients with gastroesophageal reflux. Dis Esophagus 2003;16:24-8.
12. Shaheen N, Ransohoff DE Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review. JAMA 2002;287:1972-81.
13. Curvers WL, Singh R, Song LM et al. Endoscopic tri-modal imaging for detection of early neoplasia in Barretfs oesophagus: a multi-centre feasibility study using high-resolution endoscopy, autofluorescence imaging and n arrow band imaging incorporated in one endoscopy system. Gut 2008;57:167-72.
14. Kara MA, Peters FP, Rosmolen WD et al. High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barretfs esophagus: a prospective randomized crossover study. Endoscopy 2005;37:929-36.
15. Sharma R Dent J, Armstrong D et al. The development and validation of an endoscopic grading system for Barretfs esophagus: the Prague C & M criteria. Gastroenterology 2006;131:1392-9.
16. Tseng PH, Lee YC, Chiu HM et al. Prevalence and clinical characteristics of Barretfs esophagus in a Chinese general population. J Clin Gastroenterol 2008 (in press).
17. Age-specific incidence rates of major cancers in Taiwan, Taiwan Cancer Registry, Department of Health, Executive Yuan: Taiwan; 2005. Available at: http://crs.cph.ntu.edu.tw/. Assessed Aug 26, 2008.
18. Schlemper RJ, Riddell RH, Kato Y et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251-5.
19. Shaw MJ, Talley NJ, Beebe TJ et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001;96:52-7.
20. Spechler SJ. Clinical practice. Barretfs esophagus. N Engl J Med 2002;346:836-42.
21. Blot WJ, Devesa SS, Kneller RW et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
22. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-53.
23. Kim JY, Kim YS, Jung MK et al. Prevalence of Barretfs esophagus in Korea. J Gastroenterol Hepatol 2005;20:633-6.
24. Spechler SJ, Zeroogian JM, Antonioli DA et al. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994;344:1533-6.
25. Reid BJ, Weinstein WM. Barretfs esophagus and adenocarcinoma. Annu Rev Med 1987;38:477-92.
26. Reid BJ, Weinstein WM, Lewin KJ et al. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barretfs esophagus without grossly recognizable neoplastic lesions. Gastroenterology 1988;94:81-90.
27. Rex DK, Cummings OW, Shaw M et al. Screening for Barretfs esophagus in colonoscopy patients with and without heartburn. Gastroenterology 2003;125:1670-7.
28. Veldhuyzen van Zanten SJ, Thomson AB, Barkun AN et al. The prevalence of Barretfs oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy. Aliment Pharmacol Ther 2006;23:595-9.
29. Rajendra S, Kutty K, Karim N. Ethnic differences in the prevalence of endoscopic esophagitis and Barretfs esophagus: the long and short of it all. Dig Dis Sci 2004;49:237-42.
30. Burgess JN, Payne WS, Andersen HA et al. Barrett esophagus: the columnar-epithelial-lined lower esophagus. Mayo Clin Proc 1971;46:728-34.
31. Voutilainen M, Sipponen P, Mecklin JP et al. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion 2000;61:6-13.
32. Mantynen T, Farkkila M, Kunnamo I et al. The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: a 1 -year cross-sectional study in a referral area with 260,000 inhabitants. Am J Gastroenterol 2002;97:2524-9.
33. Malfertheiner P, Lind T, Willich S et al. Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosh GORD: report from the ProGORD study. Gut 2005;54:746-51.
34. Hanna S, Rastogi A, Weston AP et al. Detection of Barretfs esophagus after endoscopic healing of erosive esophagitis. Am J Gastroenterol 2006;101:1416-20.
35. Menke-Pluymers MB, Hop WC, Dees J et al. Risk factors for the development of an adenocardnoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group. Cancer 1993;72:1155-8.
36. Iftikhar SY, James PD, Steele RJ et al. Length of Barretfs oesophagus: an important factor in the development of dysplasia and adenocardnoma. Gut 1992;33:1155-8.
37. Rudolph RE, Vaughan TL, Storer BE et al. Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med 2000;132:612-20.
38. Avidan B, Sonnenberg A, Schnell TG et al. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocardnoma. Am J Gastroenterol 2002;97:1930-6.
39. Sharma P, Morales TG, Sampliner RE. Short segment Barretfs esophagus - the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol 1998;93:1033-6.
40. Schnell TG, Sontag SJ, Chejfec G. Adenocarcinomas arising in tongues or short segments of Barretfs esophagus. Dig Dis Sci 1992;37:137-43.
41. Hameeteman W, Tytgat GN, Houthoff HJ et al. Barretfs esophagus: development of dysplasia and adenocardnoma. Gastroenterology 1989;96:1249-56.
42. Hamilton SR, Smith RR, Cameron JL. Prevalence and characteristics of Barrett esophagus in patients with adenocardnoma of the esophagus or esophagogastric junction. Hum Pathol 1988;19:942-8.
43. Tu CH, Lee CT, Perng DS et al. Esophageal adenocardnoma arising from Barretfs epithelium in Taiwan. J Formos Med Assoc 2007; 106:664-8.
44. Barrett NR. The lower esophagus lined by columnar epithelium. Surgery 1957;41:881-94.
45. Skinner DB, Little AG, Ferguson MK et al. Selection of operation for esophageal cancer based on staging. Ann Surg 1986;204:391-401.
46. McClave SA, Boyce HW Jr., Gottfried MR. Early diagnosis of columnar-lined esophagus: a new endoscopic diagnostic criterion. Gastrointest Endosc 1987;33:413-6.
47. Wu CH, Wu MS, Huang SP et al. Relationship between Helicobacter pylori infection and erosive gastroesophageal reflux disease. J Formos Med Assoc 2004;103:186-90.
48. Lin JT, Wang JT, Wang TH et al. Helicobacter pylori infection in a randomly selected population, healthy volunteers, and patients with gastric ulcer and gastric adenocardnoma. A seroprevalence study in Taiwan. Scand J Gastroenterol 1993;28:1067-72.
49. Meining A, Ott R, Becker I et al. The Munich Barrett follow up study: suspicion of Barretfs oesophagus based on either endoscopy or histology only - what is the clinical significance? Gut 2004;53:1402-7.
50. Jones TF, Sharma P, Daaboul B et al. Yield of intestinal metaplasia in patients with suspected short-segment Barretfs esophagus (SSBE) on repeat endoscopy. Dig Dis Sci 2002;47:2108-ll.
51. Oberg S, Johansson J, Wenner J et al. Endoscopic surveillance of columnar-lined esophagus: frequency of intestinal metaplasia detection and impact of antireflux surgery. Ann Surg 2001;234:619-26.
52. Goda K, Tajiri H, Ikegami M et al. Usefulness of magnifying endoscopy with narrow band imaging for the detection of specialized intestinal metaplasia in columnar-lined esophagus and Barretfs adenocardnoma. Gastrointest Endosc 2007;65:36-46.
53. Sharma P, Weston AP, Topalovski M et al. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barretfs oesophagus. Gut 2003;52:24-7.
54. Hamamoto Y, Endo T, Nosho K et al. Usefulness of narrow-band imaging endoscopy for diagnosis of Barretfs esophagus. J Gastroenterol 2004;39: 14-20.